TENOFOVIR ALAFENAMIDE + EMTRICITABINE + ELVITEGRAVIR + COBICISTAT
tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat
150 mg tablet, 30
Manner of administration:Oral
Restriction (Streamlined authority code: 4522)
Indication: HIV infection
Treatment phase: Initial
Restriction (Streamlined authority code: 4470)
Indication: HIV infection
Treatment phase: Continuing
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $1,869.20 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Genvoya | |||||